Metraipolis › archive › dc_33d9b406eebe
Predictors of response and survival in cemiplimab-treated cutaneous squamous cell carcinoma: multicenter real-world evidence from Germany — Europe PMC PMID:41739240
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41739240
- DOI
- 10.1007/s00432-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T07:52:53.152Z
- SHA-256 of the archived text
f4e27fb84c39d37d8e21efca1ce3ed2fa9c20ec6488200e11da79be135c02087- Stable URL of this page
https://metraipolis.com/documento/dc_33d9b406eebe
How to cite
Predictors of response and survival in cemiplimab-treated cutaneous squamous cell carcinoma: multicenter real-world evidence from Germany — Europe PMC PMID:41739240 — Europe PMC (en), https://europepmc.org/article/MED/41739240 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_33d9b406eebe (Metraipolis archive dc_33d9b406eebe, sha256 f4e27fb84c39d37d8e21efca1ce3ed2fa9c20ec6488200e11da79be135c02087)
BibTeX
@misc{dc33d9b406eebe,
title = {Predictors of response and survival in cemiplimab-treated cutaneous squamous cell carcinoma: multicenter real-world evidence from Germany — Europe PMC PMID:41739240},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41739240},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_33d9b406eebe; sha256 f4e27fb84c39d37d8e21efca1ce3ed2fa9c20ec6488200e11da79be135c02087},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41739240. Agents can read the archived copy with the MCP tool read_document.